Page 4 - Vasculitis United News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vasculitis united. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vasculitis United Today - Breaking & Trending Today

Short Steroid Taper Tested With Tocilizumab for GCA

Results from a pilot study examining a shortened prednisone taper of 8 weeks’ length rather than 26 weeks suggest it may be possible to reduce patients duration of exposure to glucocorticoids. ....

United States , Sebastian Unizony , Harvard Medical School , Temporal Arteritis , Giant Cell Arteritis , Blood Vessels , Rheumatoid Arthritis , Geriatrics Elder Care , Elderly Concerns Of Older Adults , Clinical Research , Clinical Trials , Linical Studies ,

Unmet Needs In Managing IgAN

Chee Kay Cheung, MBCHB, MRCP, PhD, discusses unmet needs in the management of IgAN, commenting on the need for new medication and highlighting budesonide and SGLT2 inhibitors. ....

United Kingdom , Chee Kay Cheung , United Kingdom Renal Registry , Igan Nephropathy , Targetb Cell Production , Complement System , Endothelial System , Kidney Transplantation ,

Inflammatory diseases don't boost clotting risks post-COVID, study reveals

Canadian researchers found that patients with immune-mediated inflammatory diseases (IMIDs) don't face a heightened risk of venous thromboembolism events after recovering from COVID-19 compared to those without IMIDs. However, certain comorbidities can influence this risk, emphasizing the importance of individualized patient care. ....

Kateryna Kon , Venous Thromboembolism After , Among People With , Without Immune Mediated Inflammatory , Image Credit , Charlson Comorbidity Index , Coronavirus Disease Covid 19 , Covid 19 , Deep Vein Thrombosis , Immune System , Inflammatory Bowel Disease , Multiple Sclerosis , Rheumatoid Arthritis , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Venous Thromboembolism ,